We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
CVS Health Corporation (CVS) is a leading healthcare plans business with stocks listed in the US. It opened the day at US$84.99 after a previous close of US$85.35. During the day the price has varied from a low of USD84.8351 to a high of USD85.8256. The latest price was USD85.51 (25 minute delay). CVS Health Corporation is listed on the NYSE. All prices are listed in US Dollars.
How to buy shares in CVS Health Corporation
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for CVS Health Corporation. Find the share by name or ticker symbol: CVS. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until CVS Health Corporation reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$85.35, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of CVS Health Corporation, depending on your broker.
- Check in on your investment. Congratulations, you own a part of CVS Health Corporation. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- CVS Health Corporation key stats
- Compare share trading platforms
- Is CVS Health Corporation stock a buy or sell?
- CVS Health Corporation performance over time
- Can I short CVS Health Corporation shares?
- Is CVS Health Corporation suitable for ethical investing?
- Are CVS Health Corporation shares over-valued?
- CVS Health Corporation's financials
- How volatile are CVS Health Corporation shares?
- Does CVS Health Corporation pay a dividend?
- Have CVS Health Corporation shares ever split?
- Other common questions
CVS Health Corporation stock price (NYSE:CVS)Use our graph to track the performance of CVS stocks over time.
CVS Health Corporation shares at a glance
|52-week range||US$53.9911 - US$89.5479|
|50-day moving average||US$84.9837|
|200-day moving average||US$83.1618|
|Dividend yield||US$2 (2.3%)|
|Earnings per share (TTM)||US$5.463|
Where to buy CVS Health Corporation stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy CVS Health Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Considering buying CVS Health Corporation shares?Before you consider CVS Health Corporation, you'll want to hear this.
Ticker Nerd uses advanced software to track hundreds of signals and data points to find stocks before they blow up. You can get the next two hot stocks they find sent to your inbox for free.
Show me how
CVS Health Corporation price performance over time
|3 months (2021-07-23)||2.69%|
|6 months (2021-04-23)||12.44%|
|1 year (2020-10-23)||41.93%|
|2 years (2019-10-25)||31.35%|
|3 years (2018-10-25)||21.00%|
|5 years (2016-10-25)||-2.17%|
Stocks similar to CVS Health Corporation
Is CVS Health Corporation under- or over-valued?
Valuing CVS Health Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CVS Health Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CVS Health Corporation's P/E ratio
CVS Health Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, CVS Health Corporation shares trade at around 16x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
CVS Health Corporation's PEG ratio
CVS Health Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.8458. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CVS Health Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CVS Health Corporation's EBITDA
CVS Health Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$17.6 billion (£12.8 billion).
The EBITDA is a measure of a CVS Health Corporation's overall financial performance and is widely used to measure a its profitability.
CVS Health Corporation financials
|Revenue TTM||US$277.3 billion|
|Operating margin TTM||4.73%|
|Gross profit TTM||US$48.2 billion|
|Return on assets TTM||3.52%|
|Return on equity TTM||10.17%|
|Market capitalisation||US$115.5 billion|
TTM: trailing 12 months
Shorting CVS Health Corporation shares
There are currently 14.1 million CVS Health Corporation shares held short by investors – that's known as CVS Health Corporation's "short interest". This figure is 7.7% down from 15.3 million last month.
There are a few different ways that this level of interest in shorting CVS Health Corporation shares can be evaluated.
CVS Health Corporation's "short interest ratio" (SIR)
CVS Health Corporation's "short interest ratio" (SIR) is the quantity of CVS Health Corporation shares currently shorted divided by the average quantity of CVS Health Corporation shares traded daily (recently around 5.2 million). CVS Health Corporation's SIR currently stands at 2.7. In other words for every 100,000 CVS Health Corporation shares traded daily on the market, roughly 2700 shares are currently held short.
However CVS Health Corporation's short interest can also be evaluated against the total number of CVS Health Corporation shares, or, against the total number of tradable CVS Health Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CVS Health Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 CVS Health Corporation shares in existence, roughly 10 shares are currently held short) or 0.0108% of the tradable shares (for every 100,000 tradable CVS Health Corporation shares, roughly 11 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CVS Health Corporation.
Find out more about how you can short CVS Health Corporation stock.
CVS Health Corporation's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CVS Health Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
CVS Health Corporation's total ESG risk score
Total ESG risk: 18.73
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CVS Health Corporation's overall score of 18.73 (as at 12/31/2018) is excellent – landing it in it in the 19th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like CVS Health Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
CVS Health Corporation's environmental score
Environmental score: 1.92/100
CVS Health Corporation's social score
Social score: 9.06/100
CVS Health Corporation's governance score
Governance score: 2.75/100
CVS Health Corporation's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. CVS Health Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that CVS Health Corporation hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||18.73|
|Total ESG percentile||18.84|
|Level of controversy||3|
CVS Health Corporation share dividends
Dividend payout ratio: 26.95% of net profits
Recently CVS Health Corporation has paid out, on average, around 26.95% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.29% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CVS Health Corporation shareholders could enjoy a 2.29% return on their shares, in the form of dividend payments. In CVS Health Corporation's case, that would currently equate to about $2 per share.
While CVS Health Corporation's payout ratio might seem fairly standard, it's worth remembering that CVS Health Corporation may be investing much of the rest of its net profits in future growth.
CVS Health Corporation's most recent dividend payout was on 31 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 20 October 2021 (the "ex-dividend date").
Have CVS Health Corporation's shares ever split?
CVS Health Corporation's shares were split on a 2:1 basis on 6 June 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your CVS Health Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for CVS Health Corporation shares which in turn could have impacted CVS Health Corporation's share price.
CVS Health Corporation share price volatility
Over the last 12 months, CVS Health Corporation's shares have ranged in value from as little as US$53.9911 up to US$89.5479. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CVS Health Corporation's is 0.7984. This would suggest that CVS Health Corporation's shares are less volatile than average (for this exchange).
CVS Health Corporation overview
CVS Health Corporation provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail order, mail order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. Its Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. As of December 31, 2020, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
CVS Health Corporation in the news
A Resurgence In Value
California Decriminalized Shoplifting For Amounts Under $950, Guess What Happened
CVS Health Corp. stock rises Friday, outperforms market
Frequently asked questions
More guides on Finder
How to buy BITO ETF units | $39.51
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Why is the AMP share price looking up today?
Shares in the wealth management giant have been largely stable in the last 6 months.
How to invest in the Judo Capital Holdings IPO
Everything we know about the Judo Capital Holdings IPO, plus information on how to buy in.
How to invest in the Alloggio Group IPO
Everything we know about the Alloggio Group IPO, plus information on how to buy in.
How to invest in the Larvotto Resources IPO
Everything we know about the Larvotto Resources IPO, plus information on how to buy in.
How to invest in the Vulcan Steel IPO
Everything we know about the Vulcan Steel IPO, plus information on how to buy in.
How to invest in the Artrya IPO
Everything we know about the Artrya IPO, plus information on how to buy in.
How to invest in the 8 Au IPO
Everything we know about the 8 Au IPO, plus information on how to buy in.
How to invest in the Radiopharm Theranostics IPO
Everything we know about the Radiopharm Theranostics IPO, plus information on how to buy in.
What has prompted the rebound in the Kogan share price?
The online retailer’s shares have lost more than half their value in the last 12 months.
Ask an Expert